After discovering that vitamin D has anti-proliferative and pro-differentiation activities against cells expressing VDR, it was found that vitamin D can be used in therapy against other hematological malignancies, such as the lymphoid cancer types: Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, and myeloma. This evidence concerns the gene VDR and plasma cell myeloma.